Deal Library / Pharma BD Deal Intelligence

Neurocrine Biosciences Inc. — Pharma Deals

The Pharma Closeout tracks 3 deals, $4.8B in disclosed deal value, 1 with a post-close Outcome Score for Neurocrine Biosciences Inc..

Median Critic Score: 86  ·  Median Outcome Score: 54

All 3 deals

• Neurocrine Biosciences Inc. / Voyager Therapeutics Inc. — 2019 · $1.9B · Mixed — partial payoff, real shortfalls.
• Neurocrine Biosciences Inc. / Soleno Therapeutics, Inc. — 2026 · $2.9B
• Neurocrine Biosciences Inc. / Takeda Pharmaceutical Company Ltd. — 2025

← Deal Library  ·  Interactive search  ·  How we score deals